Diabetes Care Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Blood glucose monitoring devices (Self-monitoring Blood Glucose Meters, Continuous Glucose Meters, Consumables, Others), Insulin delivery devices (Insulin Syringes, Insulin Pens, Insulin Pumps, Insulin Jet Injectors), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Region Forecast 2019-2030

Diabetes care devices market size was valued at US$ 22 billion in 2023 and is anticipated to grow at US$ 31.8 billion till 2030 recording a CAGR of 5.7% from 2024-2030. Diabetes is the most widespread metabolic disorder in which patient body is unable to use the glucose due to the lack of Insulin. The major cause of diabetes is insulin deficiency secreted by beta cells of the islet of Langerhans of the pancreas. The other factors include genetically inheritance, changing lifestyle, and unhealthy diets can also cause diabetes. Diabetes further has severe effects on the body like internal damaging of organs and hence require regular monitoring and controlled level of glucose levels in the body. Diabetes care devices are user-friendly and can be operated by patients themselves; they monitor the blood glucose level and help patients to control diabetes.

There are two different type of diabetes, caused due to decreasing ability of the pancreas to produce the insulin and another is due to lack of response to the insulin. Diabetes is a chronic disease and the people suffering from diabetes needs to monitor blood glucose throughout their life. Globally, diabetes is the fourth leading cause of death. According to the International Diabetes Federation (IDF), seven Mn people are added every year to the pool of 246 Mn diabetics, which is projected to increase approximately 438 Mn by 2030. Moreover, about 3.8 Mn people die each year from diabetes. The global market is highly fragmented with the presence of several large and small vendors, due to which it witnesses an intensely competitive environment. For the development of new products, and enhance the competitiveness, most vendors partnering with other vendors in the global market.

Key Developments

• For instance, in June 2016, Ascensia Diabetes Care partnered with Medtronic for developing and marketing diabetes management solutions. Furthermore, to develop and market test strips and blood glucose meters, vendors are also undertaking strategic alliances due to which the market presents a significant opportunity for new players in the global market.
• In 2000, Minimed has launched the Continuous Glucose Monitoring System in the global diabetes care industry market which measures and store glucose values for 3 days. Further, the device is developed to store the results up to 6 or 7 days and helps to see data in the real time. For instance, Medtronic (Enlite, Guardian Realtime), Abbott (Freestyle Navigator II), and Dexcoma(G4 Platinum)